松青资本

Songqing Capital (松青资本), legally registered as Shanghai Songqing Private Fund Management Co., Ltd., is a Shanghai-based investment firm established in 2021. The fund manager focuses on early-stage and growth investments in the life-science sector, including medical devices, pharmaceuticals and brain-science technologies. According to public recruitment information, its first fund closed in April 2023 with an initial size of roughly RMB 700 million.